856850-36-7

Basic information

• Product Name: 5-BROMO-2-ETHYLAMINOPYRIDINE
• Synonyms: 5-BROMO-2-ETHYLAMINOPYRIDINE;UKRORGSYN-BB BBR-025868
• CAS NO: 856850-36-7
• Molecular Formula: C7H9BrN2
• Molecular Weight: 201.07
• Mol File: 856850-36-7.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 259.055 °C at 760 mmHg
• Flash Point: 110.473 °C
• Appearance: /
• Density: 1.491 g/cm³
• Storage Temp.: Room temperature.
• CAS DataBase Reference: 5-BROMO-2-ETHYLAMINOPYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-2-ETHYLAMINOPYRIDINE(856850-36-7)
• EPA Substance Registry System: 5-BROMO-2-ETHYLAMINOPYRIDINE(856850-36-7)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 856850-36-7(Hazardous Substances Data)

Usage

General Description

5-Bromo-2-ethylaminopyridine is a chemical compound that belongs to the class of organic compounds known as pyridines and derivatives. It's indicated by its name, it contains bromine and ethylamine components attached to a pyridine ring. Pyridines are compounds containing a pyridine ring, which is a six-member aromatic heterocycle with one nitrogen atom replacing a carbon atom. This chemical is soluble in water, and it has potential applications in various scientific fields such as organic synthesis and pharmaceutical research. However, like many chemicals, it should be handled with appropriate safety measures due to its reactivity and potential health effects.

Upstream product

• 1072-97-5 5-bromo-2-pyridylamine 
• 141-52-6 sodium ethanolate 
• 64-19-7 acetic acid 
• 7169-97-3 N-(5-bromopyridin-2-yl)acetamide 

Relevant articles and documents

NOVEL COMPOUNDS

The present invention relates to novel compounds of formula (I) and methods for the manufacture of inhibitors of deubiquitylating enzymes (DUBs). In particular, the invention relates to the inhibition of ubiquitin C-terminal hydrolase 30 or ubiquitin spec

PI3K inhibitor, preparation method and application thereof in pharmacy

The invention belongs to the technical field of pharmaceuticals and particularly relates to a PI3K inhibitor, a preparation method and application thereof in the pharmacy. The PI3K inhibitor is a compound of the structure shown by the general formula I or medically acceptable salt of the inhibitor. After the PI3K inhibitor is tested with a PI3K biochemical activity test method, the compound has excellent inhibitory activity to PI3K alpha and PI3K gamma, wherein the IC50 values of a plurality of compounds to the PI3K alpha and PI3K gamma reach nanomole grades (smaller than 100 nM). The result shows that the compounds can provide the inhibitor with better effectiveness and selectivity for curing PI3K-acted proliferative disease, and further a targeted drug for curing No. I type diabetes mellitus, lung disease, breast cancer, prostatic cancer, solid tumor, lymphoma, cardiovascular disease, rheumatoid arthritis, leukemia and the like can be hopefully developed. (Please see the general formula I in the description.).